131 related articles for article (PubMed ID: 32092486)
1. Follicular lymphoma polygenic risk score is associated with increased disease risk but improved overall survival among women in a population based case-control in Los Angeles County California.
Zhong C; Chao CR; Song JY; Weisenburger DD; Luo J; Ding YC; Neuhausen SL; Bernstein L; Cozen W; Wang SS
Cancer Epidemiol; 2020 Apr; 65():101688. PubMed ID: 32092486
[TBL] [Abstract][Full Text] [Related]
2. Medical history, lifestyle, family history, and occupational risk factors for follicular lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
Linet MS; Vajdic CM; Morton LM; de Roos AJ; Skibola CF; Boffetta P; Cerhan JR; Flowers CR; de Sanjosé S; Monnereau A; Cocco P; Kelly JL; Smith AG; Weisenburger DD; Clarke CA; Blair A; Bernstein L; Zheng T; Miligi L; Clavel J; Benavente Y; Chiu BC
J Natl Cancer Inst Monogr; 2014 Aug; 2014(48):26-40. PubMed ID: 25174024
[TBL] [Abstract][Full Text] [Related]
3. Improvements in survival after follicular lymphoma by race/ethnicity and socioeconomic status: a population-based study.
Keegan TH; McClure LA; Foran JM; Clarke CA
J Clin Oncol; 2009 Jun; 27(18):3044-51. PubMed ID: 19451447
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of event-free survival at 12 and 24 months and long-term mortality for non-Hodgkin follicular lymphoma patients: A study report from the Spanish Lymphoma Oncology Group.
Provencio M; Royuela A; Torrente M; Pollán M; Gómez-Codina J; Sabín P; Llanos M; Gumá J; Quero C; Blasco A; Aguiar D; García-Arroyo FR; Lavernia J; Martínez N; Morales M; Saenz-Cusi Á; Rodríguez D; Calvo V; de la Cruz-Merino L; de la Cruz MÁ; Rueda A;
Cancer; 2017 Oct; 123(19):3709-3716. PubMed ID: 28608996
[TBL] [Abstract][Full Text] [Related]
5. B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS.
Wang SS; Vajdic CM; Linet MS; Slager SL; Voutsinas J; Nieters A; Casabonne D; Cerhan JR; Cozen W; Alarcón G; Martínez-Maza O; Brown EE; Bracci PM; Turner J; Hjalgrim H; Bhatti P; Zhang Y; Birmann BM; Flowers CR; Paltiel O; Holly EA; Kane E; Weisenburger DD; Maynadié M; Cocco P; Foretova L; Breen EC; Lan Q; Brooks-Wilson A; De Roos AJ; Smith MT; Roman E; Boffetta P; Kricker A; Zheng T; Skibola CF; Clavel J; Monnereau A; Chanock SJ; Rothman N; Benavente Y; Hartge P; Smedby KE
Cancer Epidemiol Biomarkers Prev; 2022 May; 31(5):1103-1110. PubMed ID: 35244686
[TBL] [Abstract][Full Text] [Related]
6. [The clinical features, survival analysis, and geriatric assessment of 85 patients with follicular lymphoma: a single-center study].
Yin JJ; Qian L; Bai JF; Feng R; Li JT; Wang T; Zhang CL; Liu H
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):233-241. PubMed ID: 38716594
[No Abstract] [Full Text] [Related]
7. A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival.
Baecklund F; Foo JN; Bracci P; Darabi H; Karlsson R; Hjalgrim H; Rosenquist R; Adami HO; Glimelius B; Melbye M; Conde L; Liu J; Humphreys K; Skibola CF; Smedby KE
BMC Med Genet; 2014 Oct; 15():113. PubMed ID: 25294155
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal follicular lymphoma: using primary site as a predictor of survival.
Chouhan J; Batra S; Gupta R; Guha S
Cancer Med; 2016 Oct; 5(10):2669-2677. PubMed ID: 27696758
[TBL] [Abstract][Full Text] [Related]
9. Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study†.
Casulo C; Day B; Dawson KL; Zhou X; Flowers CR; Farber CM; Hainsworth JD; Cerhan JR; Link BK; Zelenetz AD; Friedberg JW
Ann Oncol; 2015 Nov; 26(11):2311-7. PubMed ID: 26362568
[TBL] [Abstract][Full Text] [Related]
10. Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma.
Cerhan JR; Bernstein L; Severson RK; Davis S; Colt JS; Blair A; Hartge P
Cancer Causes Control; 2005 Dec; 16(10):1203-14. PubMed ID: 16215871
[TBL] [Abstract][Full Text] [Related]
11. Statin use and survival in 16 098 patients with non-Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era.
Brånvall E; Ekberg S; Eloranta S; Wästerlid T; Birmann BM; Smedby KE
Br J Haematol; 2021 Nov; 195(4):552-560. PubMed ID: 34331461
[TBL] [Abstract][Full Text] [Related]
12. Early event status informs subsequent outcome in newly diagnosed follicular lymphoma.
Maurer MJ; Bachy E; Ghesquières H; Ansell SM; Nowakowski GS; Thompson CA; Inwards DJ; Allmer C; Chassagne-Clément C; Nicolas-Virelizier E; Sebban C; Lebras L; Sarkozy C; Macon WR; Feldman AL; Syrbu SI; Traverse-Glehan A; Coiffier B; Slager SL; Weiner GJ; Witzig TE; Habermann TM; Salles G; Cerhan JR; Link BK
Am J Hematol; 2016 Nov; 91(11):1096-1101. PubMed ID: 27465588
[TBL] [Abstract][Full Text] [Related]
13. Disparities in survival by insurance status in follicular lymphoma.
Goldstein JS; Nastoupil LJ; Han X; Jemal A; Ward E; Flowers CR
Blood; 2018 Sep; 132(11):1159-1166. PubMed ID: 30042094
[TBL] [Abstract][Full Text] [Related]
14. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.
Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N
Cochrane Database Syst Rev; 2012 Jan; 1():CD007678. PubMed ID: 22258971
[TBL] [Abstract][Full Text] [Related]
15. Associations between early-life growth pattern and body size and follicular lymphoma risk and survival: a family-based case-control study.
Odutola MK; van Leeuwen MT; Turner J; Bruinsma F; Seymour JF; Prince HM; Milliken ST; Hertzberg M; Trotman J; Opat SS; Lindeman R; Roncolato F; Verner E; Harvey M; Tiley C; Underhill CR; Benke G; Giles GG; Vajdic CM
Cancer Epidemiol; 2022 Oct; 80():102241. PubMed ID: 36058036
[TBL] [Abstract][Full Text] [Related]
16. Prediction of high risk for death in patients with follicular lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in first-line chemotherapy.
Murakami S; Kato H; Higuchi Y; Yamamoto K; Yamamoto H; Saito T; Taji H; Yatabe Y; Nakamura S; Kinoshita T
Ann Hematol; 2016 Aug; 95(8):1259-69. PubMed ID: 27220639
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control study.
Charbonneau B; Maurer MJ; Ansell SM; Slager SL; Fredericksen ZS; Ziesmer SC; Macon WR; Habermann TM; Witzig TE; Link BK; Cerhan JR; Novak AJ
Cytokine; 2012 Dec; 60(3):882-9. PubMed ID: 23010502
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
19. Congestive heart failure in older adults diagnosed with follicular lymphoma: A population-based study.
Kenzik KM; Mehta A; Richman JS; Kilgore M; Bhatia S
Cancer; 2018 Nov; 124(21):4221-4230. PubMed ID: 30303522
[TBL] [Abstract][Full Text] [Related]
20. Non-Hodgkin lymphoma in women: reproductive factors and exogenous hormone use.
Lee JS; Bracci PM; Holly EA
Am J Epidemiol; 2008 Aug; 168(3):278-88. PubMed ID: 18550561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
